Deleterious effects of chronic use of corticosteroids: an approach to the development of Cushing's Syndrome
Keywords:Deleterious effects; Glucocorticoide; Iatrogenic; Cushing's syndrome.
In recent decades there has been an undeniable advance in the development of new drugs, which have increased the patient's quality of life, as well as extended the life expectancy of the world population to which they have reach. However, it should be considered that exogenous substances, at supraphysiological levels, or even within normal levels, can mostly cause with deleterious effects, as is the case of corticosteroids, the focus of the study of this study. Articles from MEDLINE, PubMed, Elsevier, Nature Review were analyzed in order to explore the evolution of iatrogenic Cushing Syndrome (CS), which is related to the chronic use of Glucocorticoides (CG). For this purpose, biochemistry, mechanism of action, pharmacokinetics and metabolic effects of CG were described. The parallel with iatrogenic CS was traced in the description of the clinical diagnosis of the disease, based on the previous history of corticosteroid therapy of the patients, as well as the main techniques recommended for weaning the CG, which are with a lower degree of recurrence of the underlying disease and lower risk of adrenal insufficiency (dysfunctions of the Hypothalamus-Pituitary-Adrenal axis).
Amatruda, Jr. T. T., Hurst, M. M. & D’esopo, N. D. (1965) Certain endocrine and metabolic facets of the steroid withdrawal syndrome. J Clin Endocrinol Metab, 25, 1-207.
Amatruda, JR. T. T. et al. (1960) A study of the mechanism of the steroid with- drawal syndrome. Evidence for integrity of the hypothalamic- pituitary-adrenal system. J Clin Endocrinol Metab, 20, 339-54
Arnaldi, G. et al. (2003) Diagnosis and complications of Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab 88 (12), 5593-5602.
Berthelot, J.M., & Le Goff, B. & Maugars, Y. (2013) Side effects of corticosteroid injections: what's new? Joint Bone Spine. 80(4), 363-7. 10.1016/j.jbspin.2012.12.001. 10.1016/j.jbspin.2012.12.001
Bourdeau, I., El Ghorayeb, N., Gagnon, N. & Lacroix, A. (2018) Management of endocrine disease: Differential diagnosis, investigation and therapy of bilateral adrenal incidentalomas. Eur J Endocrinol. Aug,179(2):R57-R67. doi: 10.1530/EJE-18-0296. Epub 2018 May 10. PMID: 29748231 DOI: 10.1530/EJE-18-0296
Buchman, A. L. (2001) Side effects of corticosteroid therapy. J Clin Gastroenterol. 33(4):289-94. 10.1097/00004836-200110000-00006.
Dale, C. & Rang, M. M. (2012) Rang & Dale: farmacologia. (7a ed.), Elsevier.
Campagnolo, A. M. et al. (2008) Injeção de corticosteroide em patologias vocais inflamatórias crônicas, revisão da literatura. Rev. Bras. Otorrinolaringol., 74(6), 926-932, <http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72992008000600017&lng=en&nrm=iso>. https://doi.org/10.1590/S0034-72992008000600017.
Chabre, O. (2014) Cushing syndrome: Physiopathology, etiology and principles of therapy. Presse Med. 43(4), 376-92. 10.1016/j.lpm.2014.02.001. 10.1016/j.lpm.2014.02.001.
Chaudhry, H. S. & Bhimji, S. S. (2018) Cushing Syndrome. In: StatPearls. Treasure Island (FL), StatPearls Publishing.
Dinsen S, Baslund B, Klose M, Rasmussen AK, Friis-Hansen L, Hilsted L & Feldt-Rasmussen U. (2013) Why glucocorticoid withdrawal may sometimes be as dangerous as the treatment itself. Eur J Intern Med. 24(8):714-20. 10.1016/j.ejim.2013.05.014. Eur J Intern Med. 25(8), 781-3.
Geer, E. (2017) The Hypothalamic-Pituitary-Adrenal Axis in Health and Disease. Springer.
Guignat, L., Bucy, C. & Bertherat, J. (2008) Glucocorticoid treatments and adrenal function. Rev Prat. 58(9):966-70. https://pubmed.ncbi.nlm.nih.gov/18672662/
Hall, J. E., & John E. (2017) Guyton & Hall Tratado de Fisiologia Médica GEN. (13a ed.). Guanabara Koogan.
Hochberg, Z., Pacak, K. & Chrousos, G. P. (2003) Endócrinas Withdrawal syndromes. Endocrine reviwes 24 (4), 523-538.
Hopkins, R. L & Leinung, M. C. (2005) Exogenous Cushing's syndrome and glucocorticoid withdrawal. Endocrinol Metab Clin North Am. 34(2), 371-84. 10.1016/j.ecl.2005.01.013.
Howlett, T. A., Rees, L. H. & Besser, G. M. (1985) Cushing's syndrome. Clin Endocrinol Metab. 14(4):911-45. 10.1016/s0300-595x(85)80083-9. 10.1016/s0300-595x(85)80083-9. https://pubmed.ncbi.nlm.nih.gov/3002679/
Kasper, D. L. et al. (2017) Harrison Medicina Interna, 2. (19a ed.), AMGH.
Kumar, V., Abbas, A. K. & Aster, J. C. (2013) Robbins patologia básica. (9a ed.), Elsevier.
Morgan, S. A, Hassan-Smith, Z. K & Lavery, G. G. (2020) Mechanisms in endocrinology: Tissue-specific activation of cortisol in Cushing’s syndrome. European Journal of Endocrinology. Volume/Issue: Volume 175: Issue 2. R81–R87. https://doi.org/10.1530/EJE-15-1237
Nelson, D. L. & Cox, Michael M. (2018) Princípios de Bioquímica de Lehninger. (7a ed.), Artmed.
Pereira A.S. et al. (2018). Metodologia da pesquisa científica. UFSM. https://repositorio.ufsm.br/bitstream/handle/1/15824/Lic_Computacao_Metodologia-Pesquisa-Cientifica.pdf?sequence=1
Romanholi, D. J. P. C. & Salgado, L. R. (2007) Síndrome de Cushing exógena e retirada de glicocorticoides. Arq Bras Endocrinol Metab, 51(8), 1280-1292, <http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27302007000800014&lng=en&nrm=iso>. http://dx.doi.org/10.1590/S0004-27302007000800014.
Runge, M. & Greganti, M. A. (2009) Netter Medicina Interna. (2a ed.), Elsevier.
Sahdev, A. et al. (2007) Imaging in Cushing’s Syndrome. <http://www.scielo.br/pdf/abem/v51n8/16.pdf>.
Síndrome da retirada: https://pubmed.ncbi.nlm.nih.gov/15850848/
Swearigen, B. & Biller, B. (2011) Cushing’s Disease. Springer.
Vidyadhar, R. S., Suyog, S. D. & Shibhani, S. H. (2019) A Case of Iatrogenic Cushing Syndrome Secondary to Application of Topical Corticosteroids. Indian Dermatol Online J. 10(4):476-478. 10.4103/idoj.IDOJ_374_18. 10.4103/idoj.IDOJ_374_18
Waeber, P. V. G. (2012) Planifier un sevrage aux glucocorticoïdes: Stratégie diagnostique et thérapeutique. Praxis (2003), 92, 1675-1682. https://doi.org/10.1024/0369-83220.127.116.115.
Young Jr., W. (2011) The Netter Collection of Medical Illustrations, Volume 2: Endocrine System. (2a ed.), Elsevier.
How to Cite
Copyright (c) 2021 Francisco Rômulo Soares Tavares; Erivaldo Rumão da Luz ; Carlos Eduardo Guedes da Silva; Joao Manoel Lima de Barros Carvalho ; Aleson Pereira de Sousa; Maria Denise Leite Ferreira
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.